Galderma announced its new Epiduo TAP (Treatment, Adherence, and Performance) Program, an online and mobile patient platform that educates acne patients ages 13 and older about the proper application of Epiduo (adapalene and benzoyl peroxide 0.1%/2.5%) Gel and encourages acne patients to stay adherent to treatment through an interactive and integrated performance-based platform. Through the program's incentive-based system, patients are coached to follow their daily skincare regimen via text and email reminders. These reminders may help patients stay more compliant with their treatment, which could improve treatment outcomes, and help prevent future breakouts. For more information about Epiduo and the TAP Program, visit www.epiduo.com.